Nykode Therapeutics Announces Expansion of Oncology Pipeline

omvo
NYKD 14.12.2023 kl 08:29 3081

https://newsweb.oslobors.no/message/606580

“I am thrilled about this exciting addition to our pipeline, which underscores Nykode's dedication to creating innovative solutions for an expanding range of patients in need of alternative therapies,” said Mikkel W. Pedersen, Nykode’s Chief Scientific Officer. “Additionally, it signifies our belief in the promise of cancer vaccines across all stages of cancer development."
omvo
19.12.2023 kl 08:28 1973

Regner med den J.P. Morgan-kontoen som har handlet nesten 3 millioner aksjer siden oktober tok imot bra med aksjer i går.
Ny dag og nye muligheter i dag med melding om presentasjon på J.P. Morgan Healthcare Conference 10.januar
Redigert 19.12.2023 kl 08:30 Du må logge inn for å svare
omvo
18.12.2023 kl 10:04 2143

Lister seg oppover :)
Speciedaler
15.12.2023 kl 11:15 2532

Bare psykologien i markedet vil heve denne veldig raskt
omvo
15.12.2023 kl 08:59 2648

This year’s OSEBX portfolio is skewed towards industrials and healthcare. OSEBX portfolio. This year’s portfolio consists of Aker Horizons, ArcticZymes, Elkem, Hexagon Purus, Kongsberg Automotive, Nel, Nordic Semiconductor, Nykode, Photocure, and Tomra.

Nykode er en av DNB's favoritter.
keane
14.12.2023 kl 10:28 2918

Dette er vel en enormt bra mld.....
omvo
14.12.2023 kl 09:48 2979

Fra ABG i dag:
Nykode Therapeutics, NYKD NO: BUY, TP NOK 80.0